biote Corp. (BTMD): restructuring charge — Biote Q1 net income $15.8M vs loss, revenue $49.0M, restructuring 16 employees

biote Corp.

2025-Q1 EPS reported $0.37 revenue$48,992,000

Net income of $15.8M ($0.37 diluted EPS) vs net loss of $(5.7M) ($(0.12) per share) in Q1 2024.
Revenue $49.0M, up 4.7% YoY; dietary supplements +25.5%, procedure revenue -3.6%.
Adjusted EBITDA $13.8M (28.1% margin); gross profit margin 74.3% from vertical integration.
Board authorized restructuring on May 1, cutting 16 employees; completed May 5; charges $0.6-0.8M.
Company maintains 2025 financial outlook.

item 2.02 item 2.05 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

biote Corp. announced a restructuring with charges of approximately $0.6 to $0.8 million affecting commercial teams (16 employees).

Type: restructuring
Charge: approximately $0.6 to $0.8 million
Affected area: commercial teams
Headcount: 16 employees

Exact text from the filing

maximize value from existing top-tier providers and strengthen accountability and discipline throughout the organization. The Company estimates that it will incur approximately $0.6 to $0.8 million in pre-tax restructuring charges, which represent future cash expenditures for the payment of one-time severance benefits and other associated costs. The Company

View on SEC.gov

7 restructurings & charges filed in the last 30 days. Browse all restructurings & charges →

biote Corp. filing history →

Source: SEC EDGAR

accession 0000950170-25-065638

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.